Go Pro
OTCMKTS:BFNH

BioForce Nanosciences (BFNH) Stock Price, News & Analysis

BioForce Nanosciences logo
$9.25 -0.07 (-0.78%)
As of 09/21/2026 03:59 PM Eastern

About BioForce Nanosciences Stock (OTCMKTS:BFNH)

Advanced

Key Stats

Today's Range
$8.62
$9.84
50-Day Range
$1.20
$9.99
52-Week Range
$0.18
$10.99
Volume
2,336 shs
Average Volume
16,977 shs
Market Capitalization
$352.15 million
P/E Ratio
925.93
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioForce Nanosciences is a nanotechnology company that developed instrumentation, consumables and related technologies for life sciences research and nanoscale surface engineering. Its products were designed to help researchers manipulate very small volumes of liquids and create controlled patterns of biological or chemical materials on surfaces.

The company’s best-known technology was the Nano eNabler platform, also described as a molecular printer. The system used specialized dispensing tools to deposit precise quantities of fluids, enabling applications such as biomolecular patterning, microarray fabrication, cell-based research and other laboratory experiments involving nanoscale structures.

BioForce Nanosciences served research institutions, biotechnology companies and other organizations working in nanotechnology and the life sciences. Publicly available information about the company’s current operations, geographic reach and leadership is limited, and its present business status is unclear.

AI Generated. May Contain Errors.

Receive BFNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BFNH Stock News Headlines

BioForce Nanosciences Delays Annual 10-K Filing
10% yields… from a gold security?
Most stocks yield under 2%. Even gold stocks average less than 1%. One gold security, backed by one of the world's best mines, is yielding upwards of 10%. The Rothschilds, Vanguard, and BlackRock have already taken positions. With at least 8 more years of production ahead, early investors could see substantial total returns as prices start to move.tc pixel
BioForce Nanosciences Holdings, Inc. (BFNH)
BioForce Nanosciences Holdings Inc (BFNH)
See More Headlines

BFNH Stock Analysis - Frequently Asked Questions

BioForce Nanosciences' stock was trading at $0.5780 at the beginning of 2026. Since then, BFNH shares have increased by 1,500.3% and is now trading at $9.25.

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) posted its quarterly earnings data on Monday, August, 10th. The company reported $0.01 earnings per share (EPS) for the quarter.

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Charlotte's Web (CWBHF).

Company Calendar

Last Earnings
8/10/2026
Today
9/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:BFNH
CIK
1310488
Employees
3
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
925.93
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.29 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-84.67%
Return on Assets
-16.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
25.41
Quick Ratio
25.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-462.50

Miscellaneous

Outstanding Shares
38,070,000
Free Float
23,015,000
Market Cap
$352.15 million
Optionable
Not Optionable
Beta
-0.31

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:BFNH) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners